Rituximab for refractory granulomatous eye disease

References

• DeRemeeRASarcoidosis and Wegener’s granulomatosis: a comparative analysisSarcoidosis1994117188036350
   PubMedGoogle Scholar
• OharaKJudsonMABaughmanRPClinical aspects of ocular sarcoidosisDrentMCostabelUSarcoidosisWakefield, UKThe Charlesworth Group2005188209
   Google Scholar
• BaughmanRPBradleyDALowerEEInfliximab for chronic ocular inflammationInt J Clin Pharmacol Ther20054371115704608
   PubMed Web of Science ®Google Scholar
• KontkanenMPaimelaLKaarnirantaKRegression of necrotizing scleritis in Wegener’s granulomatosis after infliximab treatmentActa Ophthalmol201088e96e9719758399
   PubMed Web of Science ®Google Scholar
• JosselinLMahrACohenPInfliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patientsAnn Rheum Dis2008671343134618445626
   PubMed Web of Science ®Google Scholar
• TakeuchiTTatsukiYNogamiYPostmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritisAnn Rheum Dis20086718919417644554
   PubMed Web of Science ®Google Scholar
• PhamTClaudepierrePDeprezXAnti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR)Joint Bone Spine200572Suppl 1S1S5815978467
   PubMedGoogle Scholar
• KeoghKAYtterbergSRFervenzaFCCarlsonKASchroederDRSpecksURituximab for refractory Wegener’s granulomatosis: report of a prospective, open-label pilot trialAm J Respir Crit Care Med200617318018716224107
   PubMed Web of Science ®Google Scholar
• StoneJHMerkelPASpieraRRituximab versus cyclophosphamide for ANCA-associated vasculitisN Engl J Med201036322123220647199
   PubMed Web of Science ®Google Scholar
• BelkhouAYounsiREl BouchtiIEl HassaniSRituximab as a treatment alternative in sarcoidosisJoint Bone Spine20087551151218562234
   PubMed Web of Science ®Google Scholar
• DasilvaVBreuilVChevallierPEuller-ZieglerLRelapse of severe sarcoidosis with an uncommon peritoneal location after TNF alpha blockade. Efficacy of rituximab, report of a single caseJoint Bone Spine201077828320022779
   PubMed Web of Science ®Google Scholar
• BomprezziRPatiSChansakulCVollmerTA case of neurosarcoidosis successfully treated with rituximabNeurology20107556857020697110
   PubMed Web of Science ®Google Scholar
• BaughmanRPLowerEEBradleyDARaymondLAKaufmanAEtanercept for refractory ocular sarcoidosis: results of a double-blind randomized trialChest20051281062106716100213
   PubMed Web of Science ®Google Scholar
• BoulterELEleftheriouDSebireNJEdelstenCBroganPAInflammatory lesions of the orbit: a single paediatric rheumatology centre experienceRheumatology (Oxford)2012511070107522298792
   PubMed Web of Science ®Google Scholar
• BaughmanRPLowerEEKaufmanAHOcular sarcoidosisSemin Respir Crit Care Med20103145246220665395
   PubMed Web of Science ®Google Scholar
• AvshovichNBoulmanNSlobodinGZeinaARRosnerIRozenbaumMRefractory Wegener’s granulomatosis: effect of rituximab on granulomatous bilateral orbital involvementIsr Med Assoc J20091156656819960854
   PubMed Web of Science ®Google Scholar
• Martinez Del PeroMChaudhryAJonesRBSivasothyPJaniPJayneDB-cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort studyClin Otolaryngol20093432833519673980
   PubMed Web of Science ®Google Scholar
• OokaSMaedaAItoHOmataMYamadaHOzakiSTreatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener’s granulomatosis: a case reportMod Rheumatol200919808318806927
   PubMed Web of Science ®Google Scholar
• TaylorSRSalamaADJoshiLPuseyCDLightmanSLRituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosisArthritis Rheum2009601540154719404964
   PubMed Web of Science ®Google Scholar
• JoshiLLightmanSLSalamaADShirodkarALPuseyCDTaylorSRRituximab in refractory ophthalmic Wegener’s granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effectiveOphthalmology20111182498250321907416
   PubMed Web of Science ®Google Scholar
• CheungCMMurrayPISavageCOSuccessful treatment of Wegener’s granulomatosis associated scleritis with rituximabBr J Ophthalmol200589154216234479
   PubMed Web of Science ®Google Scholar
• HenesJCFritzJKochSRituximab for treatment-resistant extensive Wegener’s granulomatosis – additive effects of a maintenance treatment with leflunomideClin Rheumatol2007261711171517502992
   PubMed Web of Science ®Google Scholar
• JonesRBTervaertJWHauserTRituximab versus cyclophosphamide in ANCA-associated renal vasculitisN Engl J Med201036321122020647198
   PubMed Web of Science ®Google Scholar
• LowerEEBlauRGazderPTummalaRThe risk of premature menopause induced by chemotherapy for early breast cancerJ Womens Health Gend Based Med1999894995410534297
   PubMedGoogle Scholar
• Talar-WilliamsCHijaziYMWaltherMMCyclophosphamide- induced cystitis and bladder cancer in patients with Wegener granulomatosisAnn Intern Med19961244774848602705
   PubMed Web of Science ®Google Scholar
• AksoySDizdarOHayranMHarputluogluHInfectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysisLeuk Lymphoma20095035736519263297
   PubMed Web of Science ®Google Scholar
• SalliotCDougadosMGossecLRisk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trialsAnn Rheum Dis200968253218203761
   PubMed Web of Science ®Google Scholar
• LaniniSMolloyACFinePEPrenticeAGIppolitoGKibblerCCRisk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysisBMC Med201193621481281
   PubMed Web of Science ®Google Scholar
• TesfaDAjeganovaSHagglundHLate-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infectionsArthritis Rheum2011632209221421560117
   PubMed Web of Science ®Google Scholar
• LowerEESmithJTMarteloOJBaughmanRPThe anemia of sarcoidosisSarcoidosis1988551553381019
   PubMedGoogle Scholar
• BrownePMSharmaOPSalkinDBone marrow sarcoidosisJAMA19782404350660809
   PubMed Web of Science ®Google Scholar
• PopaCLeandroMJCambridgeGEdwardsJCRepeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrsRheumatology (Oxford)20074662663017189244
   PubMed Web of Science ®Google Scholar
• CabanillasFLiboyIPaviaORiveraEHigh incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: a frequently unrecognized and easily treatable complicationAnn Oncol2006171424142716966368
   PubMed Web of Science ®Google Scholar
• TreonSPIoakimidisLSoumeraiJDPrimary therapy of Waldenstrom macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180J Clin Oncol2009273830383519506160
   PubMed Web of Science ®Google Scholar